Search results for "Coco"

showing 10 items of 402 documents

Glucocorticoid receptor expression on human B cells in response to acute heavy resistance exercise.

2011

<i>Objective:</i> To examine glucocorticoid receptor (GCR) expression on B lymphocytes in response to an acute bout of resistance exercise. <i>Methods:</i> Using a within-subject design, resistance-trained women (n = 7; age: 22.13 ± 3.09 years; height: 1.69 ± 0.084 m; body weight: 65.60 ± 10.01 kg; body mass index: 22.63 ± 2.03 kg/m<sup>2</sup>; means ± SD) and men (n = 8; age: 23.28 ± 4.26 years; height: 1.73 ± 0.086 m; body weight: 73.93 ± 12.71 kg; body mass index: 24.51 ± 2.61 kg/m<sup>2</sup>; means ± SD) performed an acute resistance exercise protocol (6 sets of 5 repetition maximum heavy squats) and a control test in a balanced, randomi…

AdultMalemedicine.medical_specialtyHydrocortisoneImmunologyPhysical ExertionB-Lymphocyte SubsetsPhysical Therapy Sports Therapy and RehabilitationBiologyYoung AdultEndocrinologyImmune systemGlucocorticoid receptorReceptors GlucocorticoidInternal medicineImmune ToleranceEndocrine systemMedicineHumansOrthopedics and Sports MedicineEndocrine and Autonomic SystemsAdrenal cortexbusiness.industryResistance trainingGeneral Medicinemedicine.anatomical_structureEndocrinologyNeurologyPhysical FitnessImmunologyFemalebusinesshuman activitiesNeuroimmunomodulation
researchProduct

Hormonal Responses of Multiset Versus Single-Set Heavy-Resistance Exercise Protocols

1997

The purpose of this study was to compare serum growth hormone (GH), testosterone (T), cortisol (C) and whole blood lactate (L) responses to single set (1S) versus multiple set (3S) heavy-resistance exercise protocols. Eight recreationally weight-trained men completed two identical resistance exercise workouts (1S vs. 3S). Blood was obtained prexcerise (PRE), immediately postexercise (0P), and 5 min (5P), 15 min (15P), 30 min and 60 min (60P) postexercise and was analyzed for GH, T, C, and L levels. For 1S and 3S, GH, L, and T significantly increased from PRE to 0P and remained significantly elevated to 60P, except for 1S. For GH, T, and L, 3S showed significantly greater increases compared…

AdultMalemedicine.medical_specialtyHydrocortisonePhysiologymedicine.drug_classRadioimmunoassayPhysical exerciseBiologyReference ValuesInternal medicinemedicineHumansTestosteroneOrthopedics and Sports MedicineLactic AcidExercise physiologyExerciseTestosteroneWhole bloodHydrocortisoneCross-Over StudiesExercise ToleranceAndrogenEndocrinologyGrowth HormoneGlucocorticoidmedicine.drugHormoneCanadian Journal of Applied Physiology
researchProduct

Acute hormonal responses to two different fatiguing heavy-resistance protocols in male athletes.

1993

To examine endogenous hormonal responses to heavy-resistance exercise, ten male strength athletes performed two fatiguing but different types of sessions on separate days. In session A the loads for the leg extensor muscles in the squat-lift exercise were maximal so that the subjects performed 20 sets at 1 repetition maximum (RM) (20 x 1 RM x 100%), whereas during session B the loads were submaximal (70%) but the subjects performed each of the 10 sets until the RM (i.e., 10 repetitions/set or 10 x 10 x 70%). The recovery time between the sets was always 3 min. A decrease of 10.3 +/- 4.7% (P < 0.001) occurred in the squat-lift in 1 RM during session A, whereas session B led to a decrease…

AdultMalemedicine.medical_specialtyHydrocortisoneWeight LiftingPhysiologymedicine.drug_classPhysical ExertionPhysical exercisePhysiology (medical)Internal medicinemedicineHumansTestosteroneLactic AcidTestosteroneFatigueMorningHydrocortisonebiologyAthletesbusiness.industrybiology.organism_classificationAndrogenHormonesEndocrinologyGrowth HormoneLactatesbusinessGlucocorticoidmedicine.drugHormoneJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct

Maximal strength and power, muscle mass, endurance and serum hormones in weightlifters and road cyclists.

2004

Maximal strength, power, muscle cross-sectional area, maximal and submaximal cycling endurance characteristics and serum hormone concentrations of testosterone, free testosterone and cortisol were examined in three groups of men: weightlifters (n = 11), amateur road cyclists (n = 18) and age-matched controls (n = 12). Weightlifters showed 45-55% higher power values than road cyclists and controls, whereas the differences in maximal strength and muscle mass were only 15% and 20%, respectively. These differences were maintained when average power output was expressed relative to body mass or relative to muscle cross-sectional area. Road cyclists recorded 44% higher maximal workloads, whereas …

AdultMalemedicine.medical_specialtyHydrocortisoneWeight Liftingmedicine.drug_classPhysical Therapy Sports Therapy and RehabilitationMuscle massInternal medicineMaximal strengthmedicineHumansOrthopedics and Sports MedicineTestosteroneMuscle SkeletalTestosteroneHydrocortisoneAnalysis of Variancebusiness.industryAndrogenBicyclingEndocrinologyExercise TestLactatesPhysical EndurancebusinessCyclingGlucocorticoidHormonemedicine.drugJournal of sports sciences
researchProduct

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.

2021

OBJECTIVE To describe the efficacy and safety of biologics for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). METHODS A retrospective European collaborative study was conducted in patients with EGPA who received treatment with biologics for refractory and/or relapsing disease. RESULTS Among the 147 patients with EGPA included in the study, 63 received rituximab (RTX), 51 received mepolizumab (MEPO), and 33 received omalizumab (OMA). At the time of inclusion, the median Birmingham Vasculitis Activity Score (BVAS) was 8.5 (interquartile range [IQR] 5-13) in the RTX group, while the median BVAS in the OMA group was 2 (IQR 1-4.5) and the median BVAS in the MEPO group was…

AdultMalemedicine.medical_specialtyImmunologyBirmingham Vasculitis Activity ScoreOmalizumabOmalizumabChurg-Strauss SyndromeAntibodies Monoclonal Humanized03 medical and health sciences0302 clinical medicineRheumatologyInterquartile rangeRecurrenceInternal medicinemedicineImmunology and AllergyHumansImmunologic Factors030212 general & internal medicineTreatment FailureAdverse effectGlucocorticoidsAgedRetrospective Studies030203 arthritis & rheumatologyBiological Productsbusiness.industryMiddle Agedmedicine.diseaseAsthmaTreatment OutcomeRituximabFemaleVasculitisbusinessGranulomatosis with polyangiitisRituximabMepolizumabmedicine.drugArthritisrheumatology (Hoboken, N.J.)References
researchProduct

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.

2000

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) of unknown etiology frequently requiring long-term therapy for control of symptoms and prevention of relapse. Azathioprine (AZA) has been shown to be effective and safe in the treatment of chronic active UC. However, the alternatives to treatment with AZA are limited. Our aim was to compare the efficacy and safety of treatment with mycophenolate mofetil (MMF)/prednisolone versus standard immunosuppressive treatment with azathioprine (AZA)/prednisolone in patients with chronic active UC.The study was designed as an open comparison of MMF versus AZA. Twenty-four patients with active UC (Rachmilewitz scoreor =6 points) were randoml…

AdultMalemedicine.medical_specialtyRandomizationPrednisoloneAzathioprinePilot ProjectsMycophenolateGastroenterologyMycophenolic acidInternal medicineAzathioprineMedicineHumansColitisGlucocorticoidsAgedHepatologybusiness.industryChronic ActiveRemission InductionGastroenterologyMiddle AgedMycophenolic Acidmedicine.diseaseUlcerative colitisSurgeryChronic DiseasePrednisoloneColitis UlcerativeDrug Therapy CombinationFemalebusinessImmunosuppressive Agentsmedicine.drugThe American journal of gastroenterology
researchProduct

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in…

2004

Summary Background  Topical application of clobetasol-17-propionate has been diffusely reported as an efficacious therapy in atrophic/erosive oral lichen planus (OLP), without exposing the patient to systemic side-effects. However, prolonged contact and respective topical effects on the oral mucosa should be avoided. Objectives  The aim of the present study was to evaluate efficacy and compliance of new lipid microspheres loaded with 0·025% of clobetasol propionate (formulation A) compared with a commonly used formulation (a sort of dispersion of a lipophilic ointment in a hydrophilic phase) with the same amount of drug (formulation B) in the topical treatment of OLP. Patients and methods  …

AdultMalemedicine.medical_specialtyRandomizationVisual analogue scaleAdministration TopicalChemistry PharmaceuticalAnti-Inflammatory AgentsDermatologyDosage formlaw.inventionOintmentsDrug Delivery SystemsRandomized controlled triallawMedicineHumansSingle-Blind MethodOral mucosaGlucocorticoidsAgedAged 80 and overClobetasolbusiness.industryMiddle Agedmedicine.diseaseDermatologyLipidsMicrospheresRegimenmedicine.anatomical_structureclobetasol propionate delivery lipid microspheres oral lichen planusPatient ComplianceOral lichen planusFemaleClobetasol propionatebusinessmedicine.drugLichen Planus OralThe British journal of dermatology
researchProduct

Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes

2005

Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1496-503. Epub 2005 Jul 14. Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes. Morici G, Zangla D, Santoro A, Pelosi E, Petrucci E, Gioia M, Bonanno A, Profita M, Bellia V, Testa U, Bonsignore MR. SourceDepartment of Experimental Medicine, University of Palermo, Italy. Abstract Marathon runners show increased circulating CD34+ cell counts and postexercise release of interleukin-6 (IL-6), granulocyte-colony stimulating factor (G-CSF) and flt3-ligand (Bonsignore MR, Morici G, Santoro A, Pegano M, Cascio L, Bonnano A, Abate P, Mirabella F, Profita M, Insalaco G, Gioia M, Vignola AM, Majolino I, Testa…

AdultMalemedicine.medical_specialtyReticulocytesAdolescentHydrocortisonePhysiologyCD34Physical exerciseSettore MED/10 - Malattie Dell'Apparato RespiratorioBiologySettore BIO/09 - FisiologiaMonocytesColony-Forming Units AssayBlood cellPhysiology (medical)Internal medicineGranulocyte Colony-Stimulating Factorgrowth factorscytokinemedicineHumansProgenitor cellExercise physiologyGrowth SubstancesErythropoietinExerciseangiogenetic precursorhypoxiaHypoxia (medical)Hematopoietic Stem CellsGranulocyte colony-stimulating factormedicine.anatomical_structureEndocrinologyPhysical EnduranceCytokinesFemalemedicine.symptomLeukocyte ElastaseGlucocorticoidGranulocytesmedicine.drugAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology
researchProduct

Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial.

2011

Abstract Background Steroids, the mainstay of Crohn's disease treatment, have been associated with systemic side effects. Aim To evaluate the efficacy and tolerability of beclomethasone dipropionate for maintaining remission induced by a short course of systemic steroids in patients with Crohn's ileitis with or without right colonic involvement. Methods Patients (n = 84) with active Crohn's disease who achieved remission during a 2-week prednisone run-in period were randomised to receive beclomethasone dipropionate for 24 weeks or continue prednisone for a further 2 weeks followed by placebo for 22 weeks. The primary outcome was relapse rate (Crohn's Disease Activity Index score > 150 and a…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaRemissionKaplan-Meier EstimateBeclomethasone dipropionate Crohn's disease RemissionPlaceboGastroenterologyDrug Administration ScheduleMedication Adherencelaw.inventionDouble blindCrohn DiseaseDouble-Blind MethodRandomized controlled triallawPrednisoneInternal medicineSecondary PreventionmedicineHumansIleitisAdverse effectGlucocorticoidsAgedCrohn's diseaseHepatologybusiness.industryRemission InductionBeclomethasoneGastroenterologyBeclomethasone dipropionate Crohn's ileitis:.Middle Agedmedicine.diseaseSurgeryBeclomethasone dipropionateCrohn's diseaseTreatment OutcomeTolerabilityPrednisoneFemaleTablets Enteric-Coatedbusinessmedicine.drug
researchProduct

Influence of perioperative dexamethasone on delayed union in mandibular fractures: a clinical and radiological study

2014

Background: The aim was to clarify the occurrence of delayed union after surgical treatment of mandibular fracture and investigate whether an association exists between perioperative use of dexamethasone and delayed union. Material and Methods: Thirty-seven patients were included in a prospective randomized study. Of these patients, 19 (51.4%) were randomized to receive a total dose of 30 mg of dexamethasone and 18 (48.6%) served as controls. Patients underwent clinical and radiological investigation immediately, one month, three months and six months postoperatively. Radiographs were evaluated by an experienced, blinded senior oral radiologist. Results: Delayed fracture union was found in …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentMandibular fractureOdontologíaBone healingDexamethasonelaw.inventionYoung AdultRandomized controlled triallawMandibular FracturesmedicineHumansProspective StudiesYoung adultProspective cohort studyGeneral DentistryGlucocorticoidsDexamethasoneFracture Healingbusiness.industryResearchPerioperativeMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryRadiographyOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASSurgeryFemaleOral Surgerybusinessmedicine.drug
researchProduct